Status:
COMPLETED
CoCo-20: a Longitudinal Follow-up Study of the French Paediatric Population During and After the Coronavirus Pandemic COVID-19
Lead Sponsor:
Fondation Lenval
Conditions:
Mental Health Disorder
Eligibility:
All Genders
Up to 17 years
Brief Summary
In the context of a viral outbreak and of widespread quarantine measures, a significant increase in psychological disorders, such as stress or fear behaviours, had previously been observed. This distr...
Detailed Description
In the context of a viral outbreak and of widespread quarantine measures, a significant increase in psychological disorders, such as stress or fear behaviours, had previously been observed. This distr...
Eligibility Criteria
Inclusion
- Children affected by the Coronavirus disease 2019 (Covid-19) pandemic;
- Age between 0 and under 18 at the time of inclusion;
- Affiliated with a social security scheme;
- Having a good command of the French language (French);
- Children whose parents have accepted participation in the study (collection of informed consents).
Exclusion
- Children and/or young adults with a psychotic disorder or autism spectrum disorder;
- Children and/or young adults with an average intellectual disability (\< to 50);
- Person deprived of liberty by judicial or administrative decision1;
- Person subject to a period of exclusion for another search.
Key Trial Info
Start Date :
April 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04498416
Start Date
April 27 2020
End Date
July 31 2021
Last Update
April 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Pédiatriques de Nice CHU-Lenval
Nice, France